Loading clinical trials...

Efficacy and Safety of a New Sperm Capacitation Method | Clinical Trials | Clareo Health

RECRUITING

Efficacy and Safety of a New Sperm Capacitation Method

Efficacy and Safety of a New Sperm Capacitation Method: a Prospective in Vitro Study on Semen Samples

NCT06742437•Fecundis Lab SL

Summary

Prospective, multicenter research study with a split-sample design on semen samples, without intervention, to evaluate the efficacy and safety of HyperSperm, a new sperm capacitation method, in 300 semen samples with various characteristics and abnormalities, in an in vitro study over 12 months.

Eligibility

Age

18 - 60 years

Sex

MALE

Healthy Volunteers

Yes

Inclusion Criteria

•Ability to provide a semen sample via masturbation

Exclusion Criteria

•Current diagnosis of a sexually transmitted infection (STI)
•Previous diagnosis of hepatitis A, B, C, D, or HIV
•Prior participation in this study
•Participation in a clinical trial involving an intervention within the last 3 months

Locations (4)

Eugin Barcelona

Barcelona, Barcelona, Spain

Fertty

Barcelona, Barcelona, Spain

CIRH

Barcelona, Barcelona, Spain

Natuvitro

Barcelona, Barcelona, Spain

Key Dates

Start Date

January 14, 2025

Primary Completion Date

June 1, 2026

Completion Date

June 1, 2026

Last Updated

February 27, 2026

Enrollment

300

ESTIMATED participants

Conditions

Reproductive IssuesMale InfertilityAsthenozoospermiaOligozoospermiaTeratozoospermia

Interventions

Standard sperm preparation

DEVICE

HyperSperm

DEVICE

Contacts

Matias Gomez Elias, PhD

CONTACT

+34624174355 mgomezelias@fecundis.com

Effect of Pentoxifylline + CoQ10 vs CoQ10 Alone on Sperm Motility in Subfertile Men With Asthenozoospermia

NCT07252518

Asthenozoospermia

View study

RECRUITINGPHASE4

Phase IV Study to Evaluate the Efficacy and Safety of Fang Le Shu Compared to Guo Na Fen for Controlled Ovarian Stimulation in Infertile Women Undergoing in Vitro Fertilization-embryo Transfer (IVF-ET).

NCT06921395

Female Infertility

View study

RECRUITINGNA

A Novel Integrative Non-invasive Embryo Selection Approach for IVF Based on MK-RS Analysis

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 27, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Efficacy and Safety of a New Sperm Capacitation Method

Inclusion Criteria

Exclusion Criteria

Effect of Pentoxifylline + CoQ10 vs CoQ10 Alone on Sperm Motility in Subfertile Men With Asthenozoospermia

Phase IV Study to Evaluate the Efficacy and Safety of Fang Le Shu Compared to Guo Na Fen for Controlled Ovarian Stimulation in Infertile Women Undergoing in Vitro Fertilization-embryo Transfer (IVF-ET).

A Novel Integrative Non-invasive Embryo Selection Approach for IVF Based on MK-RS Analysis

Study to Verify the Efficacy of a Product Containing 125 mg of TetraSOD® for the Treatment of Male Infertility

Investigate the Efficacy of Using NMN to Improve Embryo Development Capacity.

Female Fertility, Environmental Agents and Stress Oxidant